ORK Stock Analysis: Orkla ASA | OL
Packaged Foods | OL, Norway | Market Cap: 102.767m NOK | 12M Return: -0.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 157M
EPS Trend: 98.1%
Qual. Beats: 0
Rev. Trend: 95.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Orkla ASA is a Norwegian industrial investment company that owns and develops branded consumer-oriented businesses across food, coatings, personal care, and household products. Its portfolio spans decorative paints and marine coatings, frozen pizza, condiments, ready-to-eat meals, snacks, confectionery, and bakery and plant-based foods, alongside branded consumer health products (including wound care and oral health under names such as Möllers, Jordan, and Salvequick), spices, cleaning and hygiene items, painting accessories, and health and sports nutrition. It also runs a franchised pizza business. The company is headquartered in Oslo, was founded in 1654, and trades on the Oslo Stock Exchange under the ticker ORK.
Operating as a multi-brand industrial investment company rather than a single-product manufacturer, Orkla manages a diversified portfolio of largely consumer staples brands, which is reflected in its classification under GICS Packaged Foods & Meats within the broader Consumer Staples sector. This structure allows Orkla to allocate capital across unrelated categories such as coatings, food, and personal care, sharing centralized brand-building and supply-chain capabilities across distinct operating subsidiaries.
- Jotun divestment proceeds fund branded consumer health M&A
- Branded foods margins squeezed by cocoa and dairy inflation
- Nordic private label competition pressures packaged foods volume
| Net Income: 11.4b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -0.14 > 1.0 |
| NWC/Revenue: 10.55% < 20% (prev 11.26%; Δ -0.71% < -1%) |
| CFO/TA 0.17 > 3% & CFO 15.3b > Net Income 11.4b |
| Net Debt (-2.32b) to EBITDA (9.81b): -0.24 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (981.7m) vs 12m ago -1.78% < -2% |
| Gross Margin: 49.22% > 18% (prev 50.0%; Δ -0.78% > 0.5%) |
| Asset Turnover: 79.91% > 50% (prev 78.36%; Δ 1.54% > 0%) |
| Interest Coverage Ratio: 9.44 > 6 (EBIT TTM 7.07b / Interest Expense TTM 749.0m) |
| A: 0.08 (Total Current Assets 26.3b - Total Current Liabilities 18.8b) / Total Assets 89.9b |
| B: 0.51 (Retained Earnings 45.7b / Total Assets 89.9b) |
| C: 0.08 (EBIT TTM 7.07b / Avg Total Assets 89.8b) |
| D: 1.23 (Book Value of Equity 47.6b / Total Liabilities 38.8b) |
| Altman-Z'' = 4.03 = AA |
| DSRI: 1.06 (Receivables 9.62b/8.87b, Revenue 71.8b/70.3b) |
| GMI: 1.02 (GM 50.0% / 49.22%) |
| AQI: 0.97 (AQ_t 0.50 / AQ_t-1 0.51) |
| SGI: 1.02 (Revenue 71.8b / 70.3b) |
| TATA: -0.04 (NI 11.4b - CFO 15.3b) / TA 89.9b) |
| Beneish M = -2.97 (Cap -4..+1) = A |
As of July 28, 2026, the stock is trading at NOK 103.30 with a total of 933,730 shares traded. Over the past week, the price has changed by -3.10%, over one month by -2.73%, over three months by -8.58% and over the past year by -0.48%.
Current recommended Stop Loss: 101.10 (which is 2.1% or 1.3 ATR below the current price).
Orkla ASA has no consensus analysts rating.
P/E Trailing = 16.563
P/E Forward = 15.6986
P/S = 1.4791
P/B = 2.1582
P/EG = 1.138
Revenue TTM = 71.8b NOK
EBIT TTM = 7.07b NOK
EBITDA TTM = 9.81b NOK
Long Term Debt = 12.9b NOK (from longTermDebt, last quarter)
Short Term Debt = 3.57b NOK (from shortLongTermDebt, last quarter)
Debt = 2.38b NOK (Leases only: 2.38b)
Net Debt = -2.32b NOK (calculated: Debt 2.38b - CCE 4.70b)
Enterprise Value = 100b NOK (103b + Debt 2.38b - CCE 4.70b)
Interest Coverage Ratio = 9.44 (Ebit TTM 7.07b / Interest Expense TTM 749.0m)
EV/FCF = 13.82x (Enterprise Value 100b / FCF TTM 7.27b)
FCF Yield = 7.24% (FCF TTM 7.27b / Enterprise Value 100b)
FCF Margin = 10.13% (FCF TTM 7.27b / Revenue TTM 71.8b)
Net Margin = 15.84% (Net Income TTM 11.4b / Revenue TTM 71.8b)
Gross Margin = 49.22% ((Revenue TTM 71.8b - Cost of Revenue TTM 36.4b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 1.12 (Enterprise Value 100b / Total Assets 89.9b)
Interest Expense / Debt = 31.50% (Interest Expense 749.0m / Debt 2.38b)
Taxrate = 16.72% (1.40b / 8.35b)
NOPAT = 5.89b (EBIT 7.07b * (1 - 16.72%))
Current Ratio = 1.40 (Total Current Assets 26.3b / Total Current Liabilities 18.8b)
Debt / Equity = 0.05 (Debt 2.38b / totalStockholderEquity, last quarter 47.6b)
Debt / EBITDA = -0.24 (Net Debt -2.32b / EBITDA 9.81b)
Debt / FCF = -0.32 (Net Debt -2.32b / FCF TTM 7.27b)
Total Stockholder Equity = 46.8b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.66% (Net Income 11.4b / Total Assets 89.9b)
RoE = 24.28% (Net Income TTM 11.4b / Total Stockholder Equity 46.8b)
RoCE = 11.83% (EBIT 7.07b / Capital Employed (Equity 46.8b + L.T.Debt 12.9b))
RoIC = 8.72% (NOPAT 5.89b / Invested Capital 67.5b)
WACC = 5.86% (E(103b)/V(105b) * Re(5.39%) + D(2.38b)/V(105b) * Rd(31.50%) * (1-Tc(0.17)))
Discount Rate = 5.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 71.32 | Cagr: 0.12%
[DCF] Terminal Value 75.23% ; FCFF base≈7.32b ; Y1≈7.25b ; Y5≈7.48b
[DCF] Fair Price = 123.5 (EV 117b - Net Debt -2.32b = Equity 119b / Shares 964.0m; r=8.35% [WACC [floored]]; 5y FCF grow -1.54% → 2.50% )
EPS Correlation: 98.10 | EPS CAGR: 7.46% | SUE: 0.74 | # QB: 0
Revenue Correlation: 95.15 | Revenue CAGR: 3.75% | SUE: -0.52 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.57 | Chg30d=+1.69% | Revisions=+25% | Analysts=5
EPS next Quarter (2026-09-30): EPS=1.72 | Chg30d=-1.69% | Revisions=+17% | Analysts=5
EPS current Year (2026-12-31): EPS=6.57 | Chg30d=+1.56% | Revisions=+50% | GrowthEPS=-3.8% | GrowthRev=+0.7%
EPS next Year (2027-12-31): EPS=6.89 | Chg30d=-0.05% | Revisions=+0% | GrowthEPS=+4.9% | GrowthRev=+2.8%
[Analyst] Revisions Ratio: +36% (up=8, down=3)